Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seminara

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Tumori|February 28, 1987
Anthracycline in colorectal carcinoma: an in vitro short-term assay to predict drug sensitivity. Preliminary resultsP Seminara, F Franchi, M Mulieri, et al.
Medicina (Florence, Italy)|April 1, 1989
[Clinical course and phenotypic instability in 4 cases of multiple myeloma: a biological model of tumors]P Seminara, F Franchi, G C Pisanelli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Elevated doses of carmustine and mitomycin C, with lonidamine enhancement and autologous bone marrow transplantation in the treatment of advanced colorectal cancer: results from a pilot studyF Franchi, P Seminara, G Codacci Pisanelli, et al.
Chemotherapy|January 12, 2002
In vitro models of a three-drug regimen (epirubicin, cisplatin and fluorouracil) for the treatment of colorectal cancerE Caliò, P Seminara, T Aronne, et al.
International Journal of Oncology|April 30, 2011
High-dose chemotherapy with bone marrow transplantation for advanced colorectal cancerG Codaccipisanelli, P Seminara, L Gargano, et al.
Chemotherapy|January 12, 2002
Epirubicin, cisplatin and continuous-infusion 5-fluorouracil (ECF regimen) in the treatment of advanced colorectal cancerL Gargano, E T Menichetti, M Marcellini, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 24, 1999
Nucleotide fractional incorporation: a simple metabolic feature potentially related to clinical outcome in colorectal cancer patientsF Franchi, P Seminara, L Izzo, et al.
Acta Haematologica|June 16, 2001
Activity of a nitroxylated analog of daunorubicin, ruboxyl, in B-lymphoproliferative disordersP Seminara, F Franchi, N Konovalova, et al.
European Journal of Cancer Care|May 19, 2007
Antiangiogenic metronomic chemotherapy and hyperthermia in the palliation of advanced cancerF Franchi, P Grassi, D Ferro, et al.
Tumori|July 1, 1995
Comparative in vitro and in vivo study of a nitroxyl derivative of 5-fluorouracil (magnizil) on human gastrointestinal tumorsP Seminara, G Bogdanov, G Codacci-Pisanelli, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Tumori|February 28, 1987
Anthracycline in colorectal carcinoma: an in vitro short-term assay to predict drug sensitivity. Preliminary resultsP Seminara, F Franchi, M Mulieri, et al.
Medicina (Florence, Italy)|April 1, 1989
[Clinical course and phenotypic instability in 4 cases of multiple myeloma: a biological model of tumors]P Seminara, F Franchi, G C Pisanelli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Elevated doses of carmustine and mitomycin C, with lonidamine enhancement and autologous bone marrow transplantation in the treatment of advanced colorectal cancer: results from a pilot studyF Franchi, P Seminara, G Codacci Pisanelli, et al.
Chemotherapy|January 12, 2002
In vitro models of a three-drug regimen (epirubicin, cisplatin and fluorouracil) for the treatment of colorectal cancerE Caliò, P Seminara, T Aronne, et al.
International Journal of Oncology|April 30, 2011
High-dose chemotherapy with bone marrow transplantation for advanced colorectal cancerG Codaccipisanelli, P Seminara, L Gargano, et al.
Chemotherapy|January 12, 2002
Epirubicin, cisplatin and continuous-infusion 5-fluorouracil (ECF regimen) in the treatment of advanced colorectal cancerL Gargano, E T Menichetti, M Marcellini, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 24, 1999
Nucleotide fractional incorporation: a simple metabolic feature potentially related to clinical outcome in colorectal cancer patientsF Franchi, P Seminara, L Izzo, et al.
Acta Haematologica|June 16, 2001
Activity of a nitroxylated analog of daunorubicin, ruboxyl, in B-lymphoproliferative disordersP Seminara, F Franchi, N Konovalova, et al.
European Journal of Cancer Care|May 19, 2007
Antiangiogenic metronomic chemotherapy and hyperthermia in the palliation of advanced cancerF Franchi, P Grassi, D Ferro, et al.
Tumori|July 1, 1995
Comparative in vitro and in vivo study of a nitroxyl derivative of 5-fluorouracil (magnizil) on human gastrointestinal tumorsP Seminara, G Bogdanov, G Codacci-Pisanelli, et al.
Pageof 5